Periodic interactions of GH-releasing factor and somatostatin can augment GH release in vitro

J. Weiss, M. J. Cronin, M. O. Thorner

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Growth hormone (GH) is secreted as pulses in vivo. To understand the signals governing this periodicity, we have established a perifusion-based model of pulsatile GH release. Male rat anterior pituitaries were dispersed and perifused with pulses of human growth hormone-releasing factor-(1-40) (GHRF), with or without a continuous or discontinuous somatostatin tonus. An experiment was composed of a 1-h base-line collection followed by four 3-h cycles; each contained single or paired 10-min infusion(s) of 3 nM GHRF. In testing the impact of somatostatin, the protocol was identical except that 0.3 nM somatostatin was added 30 min into the base-line period and then was either continued throughout the study or withdrawn during the periods of GHRF infusion. GH base lines with somatostatin were lower than vehicle base lines (P < 0.05). GHRF pulses generated consistent peaks of GH release between 200 and 300 ng·min-1·(107 cells)-1, and these peaks were not altered by continuous somatostatin. In contrast, withdrawal of somatostatin during GHRF administration elicited markedly higher GH peaks (P < 0.05) and more total GH release (P < 0.05). This response could not be accounted for by the additive effects of GHRF and somatostatin withdrawal.

Original languageEnglish (US)
Pages (from-to)16/5
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Issue number5
StatePublished - 1987

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)


Dive into the research topics of 'Periodic interactions of GH-releasing factor and somatostatin can augment GH release in vitro'. Together they form a unique fingerprint.

Cite this